| ADTX 0.0078 -28.44% | GDC 0.0264 -6.05% | SOXS 4.24 -8.42% | CIIT 0.6037 36.58% | VIVK 0.7093 34.08% | OBAI 1.385 24.77% | GPUS 0.3129 20.35% | NIVF 0.9819 40.27% | SPCX 207.02 2.59% | NEOV 1.88 9.94% | UTSI 3.35 13.18% | GNS 0.2269 5.68% | WOK 0.0453 -10.65% | SRXH 0.1947 2.47% | PAVS 0.1807 -6.37% | NOK 14.0199 0.29% | YYGH 0.1251 -11.28% | MCRP 2.32 11.54% | EZGO 1.495 16.80% | ELTX 3.05 10.51% | COSM 0.2519 0.84% | CRE 4.02 22.94% | BURU 0.1503 2.24% | SOXL 244.5 8.09% | INTC 119.1699 1.81% | ITOC 0.3164 -10.60% | TQQQ 80.935 1.26% | SNAP 4.795 -6.98% | SQQQ 37.88 -1.23% | TSLL 13.1681 -2.10% | CREG 2.29 10.63% | NVDA 208.265 0.41% | NXTS 5.475 -5.93% | NITO 5.475 -5.93% | SOFI 18.08 2.09% | SMR 10.05 1.62% | IBIT 36.825 -0.93% | IVDA 0.4577 -11.13% | EOSE 7.35 7.93% | OTLK 1.55 -1.27% | ASTS 85 3.34% | CLPT 17.08 28.04% | NEO 10.585 0.91% | MU 1043.11 2.19% | CONL 5.81 -0.17% | RGNT 6.875 12.70% | ADPT 16.77 -2.61% | TZA 4.1101 -1.44% | CPOP 0.148 -8.47% | CHR 1.93 -1.28%

Freshpet Surges 6% On Strong Earnings Despite Lower Sales Outlook

Freshpet (NASDAQ:FRPT) posted second-quarter results that exceeded earnings expectations, lifting shares over 6% today, despite missing revenue forecasts and trimming its sales guidance.

The company reported adjusted earnings per share of $0.33, well ahead of the $0.11 consensus. Revenue rose 12.5% year-over-year to $264.7 million, falling short of the $267.85 million forecast. Growth was driven by a 10.8% increase in volume and a 1.7% favorable price/mix.

Freshpet posted net income of $16.4 million versus a loss of $1.7 million a year ago. Gross margin improved to 40.9%, up from 39.9%, while adjusted EBITDA rose to $44.4 million from $35.1 million in the same period last year.

Freshpet lowered its 2025 net sales growth forecast to 13–16%, down from 15–18%, citing consumer economic pressures. However, it maintained its adjusted EBITDA target of $190–$210 million and reduced its capital spending outlook to $175 million from $225 million.

The company also withdrew its long-term $1.8 billion sales target for 2027 but reaffirmed its adjusted gross margin goal of 48% and EBITDA margin target of 22%.

Published on: August 4, 2025